Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for keratinocyte carcinoma

Event

RME Collaborative Oncology Congress

Overview & Learning Objectives

• Evaluate the latest clinical evidence on the safety and efficacy of systemic therapies for the treatment of non-melanoma skin cancer
• Apply current guideline recommendations and recent clinical trial data to optimize treatment for patients with non-melanoma skin cancer
• Utilize evidence-based approaches to monitor, recognize, and mitigate adverse effects associated with systemic therapies for non-melanoma skin cancer
• Integrate interprofessional strategies to optimize management and outcomes of patients with non-melanoma skin cancer, particularly in rural and underserved communities